A detailed history of Tfg Advisers LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Tfg Advisers LLC holds 20,719 shares of ABBV stock, worth $3.63 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
20,719
Previous 20,926 0.99%
Holding current value
$3.63 Million
Previous $3.59 Million 13.99%
% of portfolio
1.49%
Previous 1.41%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $33,914 - $41,261
-207 Reduced 0.99%
20,719 $4.09 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $12,692 - $14,822
82 Added 0.39%
20,926 $3.59 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $46,187 - $52,626
289 Added 1.41%
20,844 $3.8 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $67,011 - $75,470
487 Added 2.43%
20,555 $3.19 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $94,448 - $109,337
707 Added 3.65%
20,068 $2.99 Million
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $69,965 - $87,067
528 Added 2.8%
19,361 $2.61 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $158,492 - $182,527
1,096 Added 6.18%
18,833 $3 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $140,108 - $168,026
1,013 Added 6.06%
17,737 $2.87 Million
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $192,591 - $220,889
1,435 Added 9.39%
16,724 $2.25 Million
Q2 2022

Jul 20, 2022

BUY
$137.62 - $174.96 $92,205 - $117,223
670 Added 4.58%
15,289 $2.34 Million
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $32,863 - $40,773
249 Added 1.73%
14,619 $2.37 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $38,782 - $49,070
361 Added 2.58%
14,370 $1.95 Million
Q3 2021

Oct 21, 2021

BUY
$106.4 - $120.78 $10,959 - $12,440
103 Added 0.74%
14,009 $1.51 Million
Q2 2021

Jul 19, 2021

SELL
$105.21 - $117.21 $13,046 - $14,534
-124 Reduced 0.88%
13,906 $1.57 Million
Q1 2021

Apr 23, 2021

BUY
$102.3 - $112.62 $39,487 - $43,471
386 Added 2.83%
14,030 $1.52 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $44,752 - $60,420
556 Added 4.25%
13,644 $1.46 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $99,483 - $116,761
1,158 Added 9.71%
13,088 $1.15 Million
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $65,372 - $87,478
891 Added 8.07%
11,930 $1.17 Million
Q1 2020

Apr 24, 2020

BUY
$64.5 - $97.79 $23,736 - $35,986
368 Added 3.45%
11,039 $841,000
Q4 2019

Mar 16, 2020

BUY
$72.13 - $90.25 $10,603 - $13,266
147 Added 1.4%
10,671 $944,000
Q3 2019

May 01, 2020

SELL
$62.98 - $75.72 $3,967 - $4,770
-63 Reduced 0.6%
10,524 $796,000
Q2 2019

May 01, 2020

SELL
$65.7 - $83.98 $5,058 - $6,466
-77 Reduced 0.72%
10,587 $769,000
Q1 2019

Apr 30, 2020

BUY
$77.14 - $90.79 $76,137 - $89,609
987 Added 10.2%
10,664 $859,000
Q4 2018

Apr 29, 2020

BUY
$77.85 - $96.01 $753,354 - $929,088
9,677 New
9,677 $892,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tfg Advisers LLC Portfolio

Follow Tfg Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Advisers LLC with notifications on news.